Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 60 (3) , 431-459
- https://doi.org/10.1016/0163-7258(93)90031-8
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemiaJournal of Internal Medicine, 1991
- Prevention of restenosis by lovastatin after successful coronary angioplastyAmerican Heart Journal, 1991
- Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoBiochemical and Biophysical Research Communications, 1989
- HMG-CoA Reductase Inhibitors for HypercholesterolemiaNew England Journal of Medicine, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Drug Kinetics and Hepatic Blood FlowClinical Pharmacokinetics, 1979